Correlation Between Inhibrx and 06368FAC3

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and 06368FAC3 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and 06368FAC3 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and BMO 125 15 SEP 26, you can compare the effects of market volatilities on Inhibrx and 06368FAC3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of 06368FAC3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and 06368FAC3.

Diversification Opportunities for Inhibrx and 06368FAC3

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Inhibrx and 06368FAC3 is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and BMO 125 15 SEP 26 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BMO 125 15 and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with 06368FAC3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BMO 125 15 has no effect on the direction of Inhibrx i.e., Inhibrx and 06368FAC3 go up and down completely randomly.

Pair Corralation between Inhibrx and 06368FAC3

Given the investment horizon of 90 days Inhibrx is expected to generate 6.75 times more return on investment than 06368FAC3. However, Inhibrx is 6.75 times more volatile than BMO 125 15 SEP 26. It trades about 0.03 of its potential returns per unit of risk. BMO 125 15 SEP 26 is currently generating about -0.03 per unit of risk. If you would invest  1,419  in Inhibrx on September 13, 2024 and sell it today you would earn a total of  81.00  from holding Inhibrx or generate 5.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy96.0%
ValuesDaily Returns

Inhibrx  vs.  BMO 125 15 SEP 26

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
BMO 125 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BMO 125 15 SEP 26 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 06368FAC3 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Inhibrx and 06368FAC3 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and 06368FAC3

The main advantage of trading using opposite Inhibrx and 06368FAC3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, 06368FAC3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 06368FAC3 will offset losses from the drop in 06368FAC3's long position.
Inhibrx vs. Crinetics Pharmaceuticals
Inhibrx vs. Merus BV
Inhibrx vs. Lyell Immunopharma
Inhibrx vs. Kronos Bio
The idea behind Inhibrx and BMO 125 15 SEP 26 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
06368FAC3 vs. Ameriprise Financial
06368FAC3 vs. Franklin Credit Management
06368FAC3 vs. Ralph Lauren Corp
06368FAC3 vs. SEI Investments
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY